No definition available.
Viral agents as the cause of diseases classified to other chapters
AB1_VIRAL_INOTHER
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
838 |
4. Check minimum number of eventsNone |
838 |
5. Include endpointsNone |
838 |
6. Filter based on genotype QC (FinnGen only) |
800 |
Control definitions (FinnGen only)
- Control exclude
- AB1_BACT_BIR_OTHER_INF_AGENTS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Viral agents as the cause of diseases classified to other chapters
based on the number of shared cases.
Similar with more cases:
- Viral agents as the cause of diseases classified to other chapters
- Bacterial, viral and other infectious agents
- Bacterial, viral and other infectious agents
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5957 | 3647 | 2291 |
| Only index persons | 4638 | 3028 | 1610 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.10 | 0.06 |
| Only index persons | 0.09 | 0.11 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 33.79 | 33.38 | 34.36 |
| Only index persons | 42.90 | 39.38 | 49.53 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 800 | 476 | 324 |
| Unadjusted period prevalence (%) | 0.16 | 0.17 | 0.15 |
| Median age at first event (years) | 50.18 | 44.59 | 58.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 837
- Matched controls
- 8370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
+∞
307.7
523
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
75.9
276.7
150
24
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
119.3
257.2
131
13
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
69.2
216.7
119
20
N72
ICD-10 Finland
Inflammatory disease of cervix uteri
85.2
184.6
98
13
B97.4
ICD-10 Finland
Respiratory syncytial virus as the cause of diseases classified to other chapters
2174.3
179.9
168
*
ZXC10
NOMESCO Finland
Use of laser
16.2
126.0
112
79
ULA02
NOMESCO Finland
Kolposcopy
6.9
124.9
237
456
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
6.8
120.8
229
439
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
6.3
83.5
160
304
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
8.3
80.3
113
154
DHA10
NOMESCO Finland
Biopsy of cavity of nose
24.5
76.5
55
24
DQA10
NOMESCO Finland
Biopsy of larynx
32.3
65.9
43
14
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
29.4
62.5
42
15
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.1
58.5
136
304
ZXD10
NOMESCO Finland
Scheduled procedure
3.0
54.9
437
2208
Z2221
NOMESCO Finland
Medical doctor
3.1
54.1
355
1607
LDA10
NOMESCO Finland
Curettage of cervix uteri
6.2
53.0
96
170
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
22.7
52.8
39
18
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
15.8
51.4
45
30
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.9
50.0
177
544
N87.0
ICD-10 Finland
Mild cervical dysplasia
8.2
49.9
69
91
ZXE00
NOMESCO Finland
One hour or less
2.8
47.6
440
2356
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
42.8
308
1431
DHB20
NOMESCO Finland
Polypectomy of internal nose
11.3
41.2
44
41
B977, D141,
ICD-10 Finland
+∞
37.8
36
*
B97.2
ICD-10 Finland
Coronavirus as the cause of diseases classified to other chapters
+∞
35.7
34
*
N771, B977,
ICD-10 Finland
+∞
35.7
34
*
DHB10
NOMESCO Finland
Excision of lesion of internal nose
58.3
33.5
39
7
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
77.5
33.1
37
5
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
46.5
33.1
40
9
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.4
32.8
67
132
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
31.1
359
2024
ZXD20
NOMESCO Finland
Day surgery
3.0
30.1
154
584
R4110
NOMESCO Finland
Physiotherapy
2.4
29.6
293
1539
ZXA10
NOMESCO Finland
Bilateral
2.6
28.6
198
878
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.1
28.5
82
214
ZXA05
NOMESCO Finland
Left side
2.5
28.4
239
1164
B977, D140,
ICD-10 Finland
+∞
28.3
27
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
6.0
28.0
51
90
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.1
27.4
130
471
J33.0
ICD-10 Finland
Polyp of nasal cavity
5.7
26.8
51
94
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
7.4
26.5
39
55
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
26.8
26.4
36
14
B97.8
ICD-10 Finland
Other viral agents as the cause of diseases classified to other chapters
268.5
25.8
26
*
WX402
NOMESCO Finland
General anaesthesia
2.3
24.2
226
1141
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
24.1
23
*
ZXA00
NOMESCO Finland
Right side
2.2
23.3
249
1328
B97.0
ICD-10 Finland
Adenovirus as the cause of diseases classified to other chapters
+∞
23.0
22
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
22.8
223
1145
A63.0
ICD-10 Finland
Anogenital (venereal) warts
4.1
21.2
61
159
Z3231
NOMESCO Finland
Registered nurse
2.1
19.5
270
1575
J33.8
ICD-10 Finland
Other polyp of sinus
5.6
19.5
37
68
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
+∞
18.8
18
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.0
18.8
91
331
UDQ22
NOMESCO Finland
Microlaryngoscopy
14.1
17.9
30
22
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.8
17.0
54
151
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
16.7
211
1181
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
15.0
132
640
WX002
NOMESCO Finland
Sedation and analgesia
2.1
14.9
172
928
Z3226
NOMESCO Finland
Physiotherapist
2.1
14.8
176
959
GB3AV, ,
NOMESCO Finland
152.6
14.5
15
*
N87.1
ICD-10 Finland
Moderate cervical dysplasia
4.6
14.3
34
76
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
43.3
14.1
17
*
LEB00
NOMESCO Finland
Biopsy of vagina
6.0
14.1
25
43
D06BB04
ATC
podophyllotoxin; topical
2.8
13.8
70
261
UDQ02
NOMESCO Finland
Direct laryngoscopy
10.3
13.5
26
26
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
16.2
12.2
19
12
DMB35
NOMESCO Finland
Endoscopic excision of neoplasm or another lesion from maxillary sinus
+∞
11.5
11
*
2121A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Larynx
121.6
11.5
12
*
127
Kela drug reimbursment
Transplant complication
4.8
11.2
25
53
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
11.0
453
3503
R2110
NOMESCO Finland
Giving the first information
2.5
11.0
70
293
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
12.1
10.9
19
16
R50.9
ICD-10 Finland
Fever, unspecified
1.9
10.6
139
778
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
10.5
351
2569
D14.4
ICD-10 Finland
Benign neoplasm: Respiratory system, unspecified
111.4
10.4
11
*
J38.3
ICD-10 Finland
Other diseases of vocal cords
5.4
10.1
20
38
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.1
10.1
103
527
1420
FHL
Laryngomicroscopy
9.3
10.1
20
22
ZXD05
NOMESCO Finland
Urgent procedure
1.7
9.9
263
1810
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
9.7
138
793
J46
ICD-10 Finland
Status asthmaticus
3.8
9.7
29
78
ZXC00
NOMESCO Finland
Use of diathermy
11.5
9.6
17
15
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
7.7
9.5
21
28
WX400
NOMESCO Finland
Inhalation anesthesy
2.8
9.4
49
185
21210
ICD-8 Finland
Benign neoplasm of respiratory system, Larynx
101.1
9.4
10
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
4.4
9.4
23
53
L04AA06
ATC
mycophenolic acid; systemic
4.1
9.3
25
62
H02AB06
ATC
prednisolone; systemic
1.6
9.3
378
2873
L28
ICPC
Limited function/disability (L)
1.9
8.9
127
729
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
8.9
222
1497
R49.08
ICD-10 Finland
Other specified dysphonia
3.8
8.7
26
70
N02AX02
ATC
tramadol; systemic, rectal
1.6
8.5
329
2458
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
8.5
44
166
WX734
NOMESCO Finland
JET-ventilation
27.8
8.5
11
*
Z2446
NOMESCO Finland
Social worker
2.2
8.5
73
349
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
8.4
79
391
J01CA04
ATC
amoxicillin; systemic
1.7
8.3
681
6016
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.4
8.2
55
236
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
8.2
85
437
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.4
8.2
20
46
R01AD09
ATC
mometasone; nasal
1.5
8.2
381
2959
ZXC95
NOMESCO Finland
Use of surgical navigator
4.8
8.1
18
38
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
22.3
8.0
11
5
A63.8
ICD-10 Finland
Other specified predominantly sexually transmitted diseases
22.3
8.0
11
5
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
8.0
246
1741
R96
ICPC
Asthma
2.1
7.9
80
407
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
7.8
168
1085
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
7.8
161
1029
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
3.3
7.7
29
91
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
7.7
85
447
J01FA10
ATC
azithromycin; systemic
1.5
7.7
474
3884
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.6
7.7
45
181
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.4
7.7
53
231
DMB10
NOMESCO Finland
Radical maxillary antrotomy
12.0
7.6
13
11
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.6
425
3412
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
7.6
114
665
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
9.0
7.6
15
17
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
7.6
57
258
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
7.6
177
1169
C03CA01
ATC
furosemide; systemic
1.6
7.5
187
1256
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
7.4
226
1592
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.4
92
505
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
8.5
7.3
15
18
R03AC12
ATC
salmeterol; inhalant
2.7
7.2
37
139
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
7.2
125
760
J01AA02
ATC
doxycycline; systemic
1.5
7.2
602
5223
WW500
NOMESCO Finland
Blood transfusion
2.8
7.2
36
134
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
7.1
112
662
R01AD08
ATC
fluticasone; nasal
1.5
7.0
234
1677
A28
ICPC
Limited function/disability NOS
1.8
7.0
113
672
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
7.0
43
178
J12.8
ICD-10 Finland
Other viral pneumonia
8.4
6.8
14
17
J32.4
ICD-10 Finland
Chronic pansinusitis
4.2
6.8
18
44
A02BC02
ATC
pantoprazole; systemic
1.5
6.8
512
4318
R03AC02
ATC
salbutamol; inhalant
1.5
6.8
450
3703
R02
ICPC
Shortness of breath/dyspnoea
1.8
6.8
101
587
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
6.8
86
475
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
6.7
119
727
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.7
203
1423
AA1AD
NOMESCO Finland
CT of head and brain
1.6
6.7
186
1278
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.1
6.6
18
45
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
6.6
56
266
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
6.6
61
300
J01DA06
ATC
[U] cefuroxime
1.7
6.6
116
708
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.6
6.5
36
141
D06BB10
ATC
imiquimod; topical
2.3
6.4
47
211
SPAT1324
SPAT
Screening procedure
0.5
6.4
49
978
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
5.2
6.3
18
35
WX892
NOMESCO Finland
Monitored bed care
2.1
6.3
60
299
H02AB07
ATC
prednisone; oral
1.8
6.3
101
600
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
6.3
6
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
6.3
42
181
R4130
NOMESCO Finland
Speech therapy
2.9
6.2
29
104
L04AD02
ATC
tacrolimus; systemic
5.1
6.2
18
36
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.6
6.2
20
57
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
6.2
153
1022
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
6.1
92
537
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
6.1
573
4994
J01MA12
ATC
levofloxacin; systemic
1.7
6.0
130
838
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
175
680
2.99
32.91
2.3
1.8
—
—
—
0
0
174
688
2.93
31.61
2.4
1.9
—
—
—
0
0
225
1050
2.56
29.36
3.5
3.0
3.86
2.54
e6/l
0.60
121
583
216
995
2.58
28.91
2.7
1.9
—
—
—
0
0
230
1096
2.51
28.63
3.4
2.8
1.07
0.97
e6/l
0.17
126
625
320
1811
2.24
26.51
4.2
3.1
0.36
0.40
e6/l
0.12
234
1369
339
1991
2.18
25.35
4.4
3.3
20.42
95.32
e6/l
1.55
251
1537
135
610
2.45
18.16
3.3
2.3
32.82
34.73
u/l
0.21
115
522
533
4018
1.90
17.14
12.6
9.2
4.21
4.04
e9/l
0.84
449
3532
207
1160
2.04
16.29
3.9
3.6
559.95
366.31
ng/l
0.40
150
840
139
671
2.28
15.99
5.3
4.2
258.29
251.44
u/l
0.18
131
642
382
2716
1.75
13.74
7.9
5.2
35.62
36.00
g/l
0.60
357
2558
353
2481
1.73
13.03
2.0
1.9
93.48
95.79
pmol/l
0.45
187
1330
450
3382
1.71
12.99
9.1
6.1
57.27
56.37
%
0.85
436
3203
125
627
2.17
12.97
6.2
5.3
1.30
1.86
mmol/l
0.93
110
502
125
634
2.14
12.59
6.2
5.2
5.67
5.80
kpa
0.61
120
612
80
337
2.52
12.38
2.2
1.6
—
—
—
0
0
449
3425
1.67
11.82
9.6
6.3
27.63
28.88
%
1.52
436
3245
142
773
2.01
11.80
5.3
3.4
6.03
7.88
umol/l
1.18
125
682
45
145
3.22
11.42
2.2
1.6
101.59
110.34
u/ml
—
7
29
109
547
2.14
11.24
6.1
4.8
4.97
4.75
kpa
0.52
104
526
216
1368
1.78
11.19
3.4
2.6
3.91
6.16
e6/l
2.54
190
1234
127
685
2.01
10.78
10.9
8.7
0.63
1.08
mmol/l
0.70
108
544
127
686
2.00
10.74
10.7
8.7
5.08
5.10
kpa
0.07
121
661
127
686
2.00
10.74
10.7
8.7
11.85
12.47
kpa
0.69
121
663
173
1037
1.84
10.70
3.0
2.4
12.82
13.49
umol/l
0.53
165
967
72
311
2.44
10.56
11.4
12.7
—
—
—
0
0
705
6167
1.91
10.52
25.4
15.7
14.09
14.64
%
3.16
699
6078
418
3191
1.62
10.50
12.4
7.2
1.21
1.21
mmol/l
0.83
381
2741
172
1046
1.81
10.10
7.5
4.0
0.81
0.82
mmol/l
0.47
166
1000
62
255
2.55
10.09
2.7
1.5
—
—
—
0
0
545
4464
1.63
10.06
5.8
4.2
28.12
2230.12
e6/l
—
8
67
383
2891
1.60
9.89
11.8
6.6
1.21
1.21
mmol/l
1.54
367
2656
151
890
1.85
9.79
3.0
2.5
23.03
22.93
%
0.02
137
771
51
193
2.75
9.78
3.2
2.9
—
—
—
0
0
323
2345
1.61
9.78
4.9
3.5
30.35
31.72
u/l
0.38
313
2240
159
954
1.82
9.73
3.0
2.4
2.34
2.37
g/l
0.26
147
886
43
152
2.93
9.35
13.7
6.8
239.82
357.09
iu/ml
0.26
11
22
28
76
3.78
9.22
3.5
1.7
—
—
—
0
0
485
3909
1.57
9.17
7.8
4.9
6.51
6.62
mmol/l
0.63
463
3634
230
1557
1.66
9.10
2.4
1.9
1.09
1.10
mg/l
0.03
191
1189
590
4994
1.61
8.91
3.7
3.3
—
—
—
0
0
124
708
1.88
8.84
4.3
3.1
1.78
1.75
%
0.13
119
649
44
165
2.76
8.61
2.0
1.4
201.18
268.51
u/ml
1.07
35
94
92
480
2.03
8.52
3.6
2.7
65.02
66.96
g/l
1.37
85
445
46
178
2.68
8.48
3.0
1.7
—
—
—
0
0
45
176
2.65
8.13
1.9
1.3
—
—
—
0
0
600
5145
1.59
8.13
11.1
7.4
81.01
78.32
u/l
0.68
576
4834
431
3444
1.52
8.03
9.8
6.3
11.46
11.60
umol/l
0.10
417
3271
23
60
3.91
8.01
1.5
1.3
—
—
—
0
0
236
1655
1.59
7.94
2.9
2.2
—
—
—
0
0
34
116
3.01
7.89
1.2
1.2
2.18
4.14
u/ml
0.46
11
37
712
6392
1.76
7.85
18.1
11.6
85.81
85.12
ml/min/173m2
0.32
601
5257
144
891
1.74
7.85
10.4
6.8
1.06
1.06
mmol/l
0.02
138
840
36
128
2.89
7.78
3.3
1.7
—
—
—
0
0
73
370
2.07
7.32
3.8
4.3
124.90
128.95
g/l
0.70
73
364
52
230
2.34
7.28
1.3
1.3
—
—
—
0
0
36
133
2.78
7.27
3.3
1.6
—
—
—
0
0
36
133
2.78
7.27
3.3
1.6
—
—
—
0
0
28
90
3.18
7.19
3.5
1.6
—
—
—
0
0
44
184
2.47
6.97
3.0
1.6
—
—
—
0
0
43
179
2.48
6.88
1.7
1.2
—
—
—
0
0
34
129
2.70
6.55
1.2
1.3
—
—
—
0
0
34
129
2.70
6.55
1.2
1.3
—
—
—
0
0
37
150
2.53
6.27
2.4
2.0
0.00
0.00
g/l
-0.00
32
141
25
82
3.11
6.23
2.2
1.7
—
—
—
0
0
53
255
2.15
6.11
1.6
2.2
1.53
1.49
g/l
0.11
46
222
37
152
2.50
6.10
2.4
2.0
0.00
0.00
g/l
-0.00
32
142
753
6979
1.79
6.02
23.2
13.0
27.08
22.45
mg/l
2.91
641
5428
163
1118
1.57
5.85
3.4
2.9
2.44
2.44
mmol/l
0.13
139
989
27
97
2.84
5.78
2.5
1.6
—
—
—
0
0
27
97
2.84
5.78
2.5
1.6
—
—
—
0
0
576
5050
1.45
5.72
5.6
4.0
12.48
11.02
mm/h
1.36
551
4688
94
564
1.75
5.67
2.0
1.8
—
—
—
0
0
38
164
2.38
5.66
2.6
2.0
0.01
0.03
g/l
0.31
33
154
80
458
1.83
5.64
4.4
3.1
250.02
172.20
ng/l
0.54
71
414
80
459
1.82
5.61
2.1
1.6
—
—
—
0
0
279
2158
1.44
5.54
5.0
3.3
2.35
2.35
mmol/l
0.05
255
1934
782
7362
1.95
5.51
14.2
9.9
25.57
26.63
u/l
0.79
773
7134
202
1472
1.49
5.45
1.5
1.5
22.15
20.86
nmol/l
0.60
183
1270
28
108
2.65
5.27
2.0
1.5
—
—
—
0
0
48
236
2.10
5.26
1.8
1.6
—
—
—
0
0
539
4707
1.41
5.19
4.0
3.2
47.53
44.94
u/l
0.26
512
4444
391
3237
1.39
5.17
3.3
2.5
—
—
—
0
0
172
1226
1.51
5.14
2.1
1.5
—
—
—
0
0
67
374
1.86
5.13
1.9
1.5
—
—
—
0
0
222
1666
1.45
5.12
2.4
2.1
2.81
2.95
mg/l
0.36
196
1453
342
2774
1.39
5.09
2.8
2.4
75.51
75.75
nmol/l
0.05
320
2528
75
437
1.79
5.01
1.8
1.8
—
—
—
0
0
30
123
2.49
5.01
1.2
1.2
2.00
4.10
u/ml
1.74
14
49
44
214
2.11
4.97
2.9
2.0
—
—
—
0
0
41
797
0.49
4.91
3.7
4.2
30.84
31.55
%
0.16
32
561
47
236
2.05
4.89
2.6
2.0
1.73
2.61
ug/l
0.25
41
215
244
1885
1.42
4.76
2.7
2.1
200.36
193.71
u/l
0.07
233
1782
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
185
2.16
4.70
3.0
3.0
0.31
0.36
u/ml
0.48
22
93
29
121
2.45
4.68
1.8
1.5
—
—
—
0
0
221
1682
1.43
4.67
3.6
3.1
1613.14
1098.66
ng/l
1.11
196
1421
28
115
2.48
4.67
1.1
1.1
—
—
—
0
0
401
3372
1.36
4.65
6.1
4.7
0.00
0.00
estimate
0.50
65
642
747
6995
1.63
4.63
25.1
14.7
139.34
139.63
mmol/l
2.44
739
6820
20
70
2.90
4.52
3.0
1.5
—
—
—
0
0
20
70
2.90
4.52
3.0
1.5
—
—
—
0
0
20
70
2.90
4.52
3.0
1.5
—
—
—
0
0
813
7819
2.39
4.50
30.7
19.1
250.38
253.98
e9/l
0.79
804
7638
404
3413
1.36
4.49
4.3
3.5
0.00
0.01
estimate
0.80
63
612
204
1542
1.43
4.46
1.8
1.4
2.27
2.30
g/l
0.07
116
945
813
7823
2.37
4.42
30.6
19.1
4.47
4.52
e12/l
2.53
802
7624
400
3381
1.35
4.40
4.2
3.4
0.00
0.00
estimate
0.50
71
681
222
1707
1.41
4.40
4.4
2.7
5922.51
6667.40
umol/l
0.08
196
1517
98
638
1.61
4.36
3.4
2.6
0.21
0.22
g/l
0.18
93
605
45
233
1.98
4.33
13.7
7.9
1.57
1.38
mg/l
0.64
45
217
381
3202
1.35
4.33
3.7
2.8
185.10
109.66
ug/l
1.34
367
3007
812
7816
2.30
4.29
31.3
19.3
40.08
40.30
%
0.59
783
7391
746
7017
1.58
4.13
25.2
14.8
3.94
3.96
mmol/l
1.50
736
6824
148
1072
1.46
4.04
1.8
1.7
966.77
1190.31
nmol/l
3.06
126
830
30
137
2.23
4.00
2.0
1.4
—
—
—
0
0
41
213
1.97
3.93
1.2
1.2
—
—
—
0
0
13
32
4.11
3.91
2.2
1.3
—
—
—
0
0
13
32
4.11
3.91
2.2
1.3
—
—
—
0
0
23
94
2.49
3.91
2.0
1.5
—
—
—
0
0
28
126
2.26
3.87
2.1
1.4
—
—
—
0
0
129
920
1.48
3.81
2.4
2.5
114.99
111.00
ug/g
0.06
113
738
18
67
2.72
3.67
4.7
3.9
—
—
—
0
0
337
2834
1.32
3.63
19.4
12.5
1.35
1.20
inr
1.61
93
864
31
150
2.11
3.61
6.5
4.1
50.77
35.65
umol/l
1.35
26
136
9
266
0.33
3.60
1.2
1.4
—
—
—
0
0
40
213
1.92
3.60
1.2
1.2
—
—
—
0
0
140
1027
1.44
3.57
2.5
2.1
—
—
—
0
0
128
926
1.45
3.51
2.3
1.9
—
—
—
0
0
8
13
6.20
3.50
3.1
4.8
—
—
—
0
0
16
58
2.79
3.43
2.4
1.6
—
—
—
0
0
12
32
3.79
3.40
3.0
1.7
—
—
—
0
0
12
32
3.79
3.40
3.0
1.7
—
—
—
0
0
9
19
4.78
3.24
2.9
3.5
—
—
—
0
0
9
19
4.78
3.24
2.9
3.5
—
—
—
0
0
11
29
3.83
3.19
4.5
1.7
—
—
—
0
0
11
29
3.83
3.19
2.3
1.2
—
—
—
0
0
11
29
3.83
3.19
4.5
1.7
—
—
—
0
0
11
29
3.83
3.19
2.3
1.2
—
—
—
0
0
11
29
3.83
3.19
4.5
1.7
—
—
—
0
0
123
910
1.41
2.99
1.8
1.8
1.53
1.45
%
0.53
104
821
33
177
1.90
2.95
3.7
3.7
30.49
33.89
mg/l
0.24
26
142
33
177
1.90
2.95
3.7
3.7
74.90
86.25
mg/l
0.08
26
143
722
6842
1.40
2.87
4.6
4.6
2.79
2.80
mmol/l
0.08
688
6380
41
238
1.76
2.86
3.4
3.6
185.76
1630.24
u/ml
1.11
34
207
86
600
1.48
2.85
3.6
4.4
22.86
19.37
ug/l
0.06
65
496
70
471
1.53
2.76
7.0
4.5
100.02
77.46
ng/l
1.29
61
432
73
496
1.52
2.75
2.6
2.3
12.74
20.12
au/ml
—
10
38
41
241
1.74
2.75
1.6
1.7
—
—
—
0
0
7
14
5.03
2.73
14.6
11.4
—
—
—
0
0
15
60
2.53
2.71
4.9
2.0
—
—
—
0
0
28
147
1.94
2.68
2.4
1.6
—
—
—
0
0
12
43
2.82
2.65
1.3
1.1
—
—
—
0
0
15
61
2.49
2.63
1.9
1.3
2038.60
2167.72
e6/l
—
10
39
48
744
0.62
2.62
9.6
6.7
—
—
—
0
0
74
512
1.49
2.57
1.5
1.3
116.54
240.02
u/ml
1.38
68
471
8
20
4.03
2.57
1.3
1.1
—
—
—
0
0
8
20
4.03
2.57
2.6
1.0
—
—
—
0
0
39
231
1.72
2.57
2.6
1.7
—
—
—
0
0
42
255
1.68
2.53
3.5
1.8
—
—
—
0
0
32
180
1.81
2.51
2.5
1.5
—
—
—
0
0
11
37
3.00
2.49
4.5
1.6
—
—
—
0
0
11
37
3.00
2.49
4.5
1.6
—
—
—
0
0
18
83
2.19
2.42
2.4
2.3
—
—
—
0
0
5
8
6.28
2.37
2.8
1.5
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
23
3.50
2.27
1.1
1.0
119.25
115.13
%
—
8
23
38
235
1.65
2.17
1.5
1.5
0.02
0.09
iu/ml
—
10
41
654
6179
1.27
2.13
5.5
5.3
38.75
39.34
mmol/mol
0.95
619
5787
15
68
2.23
2.12
1.0
1.1
—
—
—
0
0
13
56
2.34
2.05
2.0
1.3
12023.63
34620.69
e6/l
—
8
32
185
1535
1.26
2.05
1.8
1.6
—
—
—
0
0
149
1209
1.28
1.98
1.3
1.3
37.20
31.80
iu/ml
0.15
51
386
56
389
1.47
1.96
1.2
1.4
—
—
—
0
0
5
11
4.57
1.94
5.0
4.3
—
—
—
0
0
67
483
1.42
1.94
14.1
5.1
2.24
1.63
mmol/l
0.54
46
350
13
58
2.26
1.91
3.7
2.4
—
—
—
0
0
9
34
2.66
1.87
2.7
3.1
62.44
88.06
nmol/l
—
9
34
704
6742
1.28
1.85
4.2
4.2
4.67
4.69
mmol/l
0.20
675
6326
18
94
1.94
1.81
1.8
1.5
—
—
—
0
0
683
6530
1.25
1.73
4.3
4.2
5.86
5.87
mmol/l
0.11
643
6016
18
96
1.89
1.71
9.1
3.2
1.22
0.99
%
0.29
18
88
12
55
2.20
1.68
1.6
2.5
—
—
—
0
0
10
40
2.52
1.67
1.0
1.1
98.23
159.72
iu/ml
—
10
40
6
19
3.17
1.66
4.2
1.5
—
—
—
0
0
89
691
1.32
1.66
2.9
2.1
350.51
363.02
nmol/l
0.24
84
646
669
6391
1.23
1.65
4.8
4.7
1.79
2.06
mu/l
0.79
639
5915
31
197
1.60
1.65
1.5
1.4
297.51
306.98
ug/g
0.10
22
112
23
135
1.72
1.64
1.1
1.1
—
—
—
0
0
60
439
1.40
1.63
1.4
1.2
33.88
35.02
au/ml
—
5
29
68
510
1.36
1.59
2.1
2.2
11.94
12.77
nmol/l
0.39
62
459
206
1776
1.21
1.59
1.6
1.7
1.51
1.40
mmol/l
0.96
190
1508
19
107
1.79
1.55
1.7
1.5
—
—
—
0
0
12
57
2.12
1.55
1.8
1.4
72.42
74.53
umol/l
0.16
12
57
12
57
2.12
1.55
1.3
1.4
—
—
—
0
0
12
57
2.12
1.55
1.0
1.2
—
—
—
0
0
676
6477
1.23
1.55
3.7
3.8
1.30
1.28
mmol/l
0.20
641
6018
698
6713
1.24
1.53
4.1
4.1
1.45
1.46
mmol/l
0.40
668
6262
9
37
2.45
1.48
7.0
3.4
—
—
—
0
0
7
28
2.51
1.45
2.7
1.2
—
—
—
0
0
67
510
1.34
1.45
3.5
2.4
55.80
68.69
ml/min/173m2
1.25
25
211
572
5416
1.18
1.41
3.8
4.0
14.49
14.57
pmol/l
0.33
545
4984
66
504
1.34
1.40
2.6
2.4
11.43
7.81
ug/l
0.48
61
451
57
427
1.36
1.37
1.3
1.4
26.18
23.57
iu/l
0.22
44
357
36
248
1.47
1.37
16.0
5.9
8.85
8.94
kpa
0.10
36
240
24
152
1.60
1.33
1.9
1.4
—
—
—
0
0
175
1521
1.19
1.24
4.3
4.0
22.73
21.34
%
0.63
79
685
17
101
1.70
1.20
1.1
1.3
—
—
—
0
0
130
1108
1.21
1.15
2.8
2.9
0.79
0.76
ug/l
0.12
89
694
202
1791
1.17
1.13
3.3
3.3
1213.72
270.40
mg/l
0.96
138
1174
232
2085
1.16
1.09
3.4
2.5
64.11
97.91
u/l
0.42
224
1952
8
41
1.96
1.09
1.1
1.0
—
—
—
0
0
8
41
1.96
1.09
2.0
1.2
—
—
—
0
0
19
122
1.57
1.03
1.1
1.1
2.94
2.00
u/ml
—
7
50
13
75
1.74
1.03
1.2
1.2
—
—
—
0
0
30
213
1.42
1.03
1.2
1.1
—
—
—
0
0
31
222
1.41
1.02
1.5
1.3
—
—
—
0
0
25
172
1.47
1.01
1.5
1.2
—
—
—
0
0
0
29
0.00
0.98
0.0
1.8
—
—
—
0
0
24
166
1.46
0.95
1.0
1.1
2.74
2.52
u/ml
0.05
17
93
20
133
1.52
0.95
3.2
2.2
17.32
16.32
%
0.44
11
71
85
713
1.21
0.91
1.8
1.6
—
—
—
0
0
77
642
1.22
0.88
3.5
3.1
—
—
—
0
0
31
229
1.37
0.88
7.6
4.0
1.35
1.37
mmol/l
0.05
31
222
8
43
1.87
0.87
1.0
1.3
—
25.71
—
0
7
55
444
1.26
0.84
2.5
3.4
4.45
4.58
pmol/l
0.64
50
391
6
31
1.94
0.84
1.0
1.1
0.32
0.31
g/l
—
6
26
11
65
1.70
0.82
1.1
1.1
17.30
7.12
iu/ml
—
6
12
6
32
1.88
0.82
1.5
1.5
—
—
—
0
0
21
147
1.44
0.80
2.7
2.0
130.69
130.49
g/l
0.01
16
111
30
225
1.35
0.79
1.4
1.5
—
193.33
—
0
9
10
163
0.61
0.79
1.6
1.6
4888.40
14936.57
e6/l
—
5
122
192
1742
1.13
0.79
1.4
1.3
0.78
1.63
u/ml
1.97
32
466
8
48
1.67
0.79
2.3
1.6
0.95
0.99
g/l
—
8
48
9
53
1.71
0.75
1.7
1.5
—
—
—
0
0
14
91
1.55
0.75
2.4
1.4
—
—
—
0
0
7
38
1.85
0.73
3.9
2.9
892.86
707.00
u/ml
—
7
38
7
39
1.80
0.72
2.3
2.6
29.43
26.28
umol/l
—
7
39
205
1883
1.12
0.69
5.1
4.7
5.48
2.45
ug/l
0.70
184
1698
11
69
1.60
0.68
4.0
2.6
17.16
20.22
ug/l
0.36
11
69
7
43
1.63
0.67
1.6
1.2
20.57
27.28
nmol/l
—
7
33
204
1878
1.11
0.66
3.8
3.8
10.27
9.49
mg/mmol
0.09
133
1206
7
44
1.60
0.65
2.4
1.7
—
—
—
0
0
7
44
1.60
0.65
1.7
1.2
—
—
—
0
0
5
30
1.67
0.61
1.0
1.1
2010.20
1604.87
miu/ml
—
5
30
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
216
2005
1.10
0.60
3.5
3.2
6.71
7.75
mmol/l
3.02
195
1711
131
1183
1.13
0.60
1.2
1.3
8.28
10.56
u/ml
0.25
41
480
0
22
0.00
0.59
0.0
1.4
—
8.44
—
0
22
13
90
1.45
0.55
2.5
1.4
—
—
—
0
0
13
90
1.45
0.55
2.5
1.4
—
—
—
0
0
13
90
1.45
0.55
2.5
1.4
—
—
—
0
0
15
107
1.41
0.55
1.0
1.1
—
—
—
0
0
121
1335
0.89
0.55
1.7
1.7
467.01
28219118.69
pmol/l
1.52
108
1134
18
133
1.36
0.55
1.7
1.6
—
—
—
0
0
21
160
1.32
0.54
1.2
1.7
14.62
10.20
e6/l
0.16
16
126
21
160
1.32
0.54
1.3
1.7
693.50
874.65
e6/l
0.07
16
130
18
134
1.35
0.53
6.4
3.9
59.89
57.97
%
0.36
18
134
13
91
1.44
0.53
2.5
1.4
—
—
—
0
0
13
91
1.44
0.53
2.5
1.4
—
—
—
0
0
6
41
1.47
0.50
1.3
1.5
206.83
171.08
pmol/l
—
6
41
24
189
1.28
0.50
1.3
1.2
—
2.64
—
0
23
14
190
0.73
0.50
1.6
1.7
—
—
—
0
0
17
222
0.76
0.47
1.3
1.5
—
—
—
0
0
10
68
1.48
0.47
1.8
1.3
—
—
—
0
0
32
264
1.22
0.46
1.3
1.3
222.68
233.67
miu/ml
0.06
12
124
7
49
1.43
0.46
1.0
1.0
—
—
—
0
0
7
49
1.43
0.46
2.6
2.1
—
—
—
0
0
7
50
1.40
0.45
1.1
1.6
—
—
—
0
0
7
50
1.40
0.45
1.0
1.1
240.57
236.00
mg/l
—
7
42
15
113
1.33
0.43
1.2
1.1
—
—
—
0
0
17
131
1.30
0.42
6.4
3.5
4.25
4.31
e9/l
0.04
17
131
0
15
0.00
0.41
0.0
1.1
—
0.04
—
0
9
49
560
0.87
0.41
1.2
1.2
122.88
150.44
iu/ml
0.18
13
218
8
61
1.31
0.39
1.1
1.2
—
—
—
0
0
8
61
1.31
0.39
1.1
1.2
—
—
—
0
0
5
35
1.43
0.39
2.6
1.8
1.20
2.00
u/field
—
5
26
31
261
1.19
0.38
1.6
1.4
—
—
—
0
0
31
261
1.19
0.38
1.6
1.4
—
—
—
0
0
11
147
0.74
0.37
2.1
3.8
29.52
25.26
mg/l
—
6
96
274
2622
1.07
0.37
4.4
3.5
—
—
—
0
0
31
262
1.19
0.37
1.6
1.4
—
—
—
0
0
31
262
1.19
0.37
1.6
1.4
—
—
—
0
0
10
72
1.39
0.37
5.1
2.8
3.50
5.54
nmol/l
—
10
72
38
328
1.17
0.36
1.5
1.6
290.16
295.57
mu/l
0.04
31
297
27
227
1.20
0.35
1.6
1.8
—
—
—
0
0
14
109
1.29
0.33
1.4
1.1
—
—
—
0
0
14
177
0.79
0.33
1.2
1.4
56.93
132.44
pmol/l
0.68
14
172
29
249
1.17
0.31
1.3
1.5
5.77
9.44
u/l
1.84
18
199
23
194
1.19
0.29
1.1
1.1
0.16
3.48
u/ml
3.09
12
111
8
62
1.29
0.28
1.1
1.2
—
—
—
0
0
8
62
1.29
0.28
1.1
1.2
—
—
—
0
0
8
62
1.29
0.28
1.1
1.2
—
—
—
0
0
21
177
1.19
0.27
2.1
1.8
1.90
5.67
iu/l
—
9
56
8
66
1.21
0.26
1.1
1.1
—
—
—
0
0
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
13
159
0.81
0.25
1.8
1.5
—
—
—
0
0
15
124
1.21
0.24
1.1
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
2.31
—
0
7
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
0.09
—
0
8
18
155
1.16
0.20
2.1
1.8
199.00
214.03
pmol/l
0.22
18
147
15
127
1.18
0.19
1.6
1.7
—
—
—
0
0
19
167
1.14
0.17
1.8
2.2
84.08
90.33
ug/min
0.03
13
100
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
155
1498
1.04
0.16
4.4
3.6
1.01
1.02
kg/l
0.98
19
214
31
283
1.10
0.16
1.7
1.5
—
—
—
0
0
6
76
0.79
0.15
1.2
1.4
296.50
379.81
pmol/l
—
6
69
16
182
0.88
0.15
1.3
1.4
—
—
—
0
0
39
419
0.93
0.14
1.1
1.0
—
—
—
0
0
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
26
280
0.93
0.10
1.7
1.9
—
—
—
0
0
5
46
1.09
0.09
1.4
1.4
—
—
—
0
0
16
145
1.11
0.09
1.2
1.1
—
11.55
—
0
13
37
351
1.06
0.08
2.4
2.2
6174.45
5313.48
u/l
0.05
11
146
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
6
70
0.86
0.07
1.2
1.2
0.93
1.40
nmol/l
—
6
61
8
77
1.04
0.07
3.8
1.3
—
—
—
0
0
45
467
0.96
0.06
1.7
1.5
—
—
—
0
0
243
2412
1.01
0.03
4.1
3.4
52.80
36.64
ng/l
0.32
160
1555
30
310
0.97
0.03
1.5
1.5
—
—
—
0
0
13
122
1.07
0.02
1.1
1.3
3.09
2.66
ug/l
0.29
13
106
51
501
1.02
0.02
6.2
3.8
1.22
1.23
mmol/l
0.44
46
441
13
124
1.05
0.00
1.2
1.3
—
—
—
0
0
181
1813
1.00
0.00
4.4
3.7
0.00
0.01
estimate
0.88
61
628
32
319
1.00
0.00
1.4
1.8
11.97
3.27
mg/l
0.78
21
234
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
60
1.00
-0.00
2.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
9.82
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
213.71
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
2.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_VIRAL_INOTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_INOTHER | 1.297 [1.03, 1.63] | 0.027 |
| Birth year | 0.997 [0.99, 1.01] | 0.466 |
During the follow-up period (1.1.1998 — 31.12.2019), 179 out of 3038 females with AB1_VIRAL_INOTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_INOTHER | 1.371 [1.09, 1.73] | 0.008 |
| Birth year | 0.988 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 200 out of 1909 males with AB1_VIRAL_INOTHER died.
Mortality risk
Mortality risk for people of age
years, who have AB1_VIRAL_INOTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.12% | 0.312% |
| 5 | 0.834% | 1.677% |
| 10 | 2.084% | 3.887% |
| 15 | 3.811% | 7.782% |
| 20 | 6.855% | 12.966% |
Relationships between endpoints
↥Index endpoint: AB1_VIRAL_INOTHER – Viral agents as the cause of diseases classified to other chapters
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data